Chicago Headache Center and Research Institute

Chicago, Illinois 60657

0 studies enrolling now · 9 studies all time

What they study most

Acute Migraine, Migraine

Studies at this site

• A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine — Running, not enrolling
• Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine — Running, not enrolling
• A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
• Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine — Completed
• A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
• Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine — Completed
• A Study of K-645 in the Treatment of Multiple Migraine Attacks — Stopped early
• A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine — Completed
• Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention — Completed